News & Events

By immersing ourselves in events and initiative, our expert teams are designed to keep you informed about the latest industry developments. Our goal is to provide essential support and tools for the success of your own groundbreaking projects.

February 13, 2024
/ Uncategorized

Curapath Strengthens Partnership in Breakthrough Genetic Medicine with Multiyear Development and Manufacturing Agreement

BOSTON and VALENCIA, Feb. 14, 2024 – Curapath, a leader in the development and custom manufacturing of polymer- and lipid-based delivery systems for advanced therapies, has...

December 15, 2023
/ Uncategorized

Curapath Appoints Philippe Clavel as Chief Executive Officer

Curapath, a developer, manufacturer, and formulator of lipid- and polymer-based nanoparticles used in advanced therapeutic delivery technology, today announced the appointment of Philippe Clavel as Chief Executive Officer....

January 26, 2023
/ Uncategorized

Curapath Receives Accreditation as a GMP Investigational Drug Product Manufacturer from the Spanish Agency for Medicine and Health Products

Valencia, Spain and Boston, MA, January 26, 2023 – Curapath, a leader in the design, development, andcustom manufacturing of polyamino-acid- and lipid nanoparticle (LNP) delivery systems...

November 14, 2022
/ Uncategorized

Curapath Announces Collaboration with Afrigen Biologics to Advance Development of African-owned mRNA SARS-CoV-2 Vaccine

Curapath will develop and optimize a process to produce a nanoparticle formulation for the vaccine Valencia, Spain and Boston, MA, November 16, 2022 – Curapath, a...

November 10, 2022
/ Uncategorized

Innovation and Technology highlights at Curapath

October 17, 2022
/ Uncategorized

Polypeptide Therapeutics Solutions (PTS) Announces Company Name Change to Curapath and Expansion of Drug Delivery Capabilities and Services

Expanded capabilities support development and production of novel functional lipid excipients and nanoparticle formulation Addition of late stage clinical and commercial-scale production is also planned Company...

News & Events

Discuss a Project